FOXP3 and cancer: Positive for progression but not clinical outcomes: Foxp3+ cells were present in previously described clusters of CD4+ lymphocytes adjacent to tumor cells but were virtually absent in carcinoma area. Collectively, Foxp3+ cells were more frequent in cancer than BPH or healthy tissue, but were not correlated with Gleason score or TNM.